The iconic apparel company came public with a bang, and Jim Cramer details why investors should wait for a pullback to get in. » Read More
Jim Cramer talks with CVS CEO Larry Merlo, who says reducing medical costs with the Aetna merger will unlock billions of dollars in value for the company. » Read More
Jim Cramer gives his playbook and stock picks for a low-growth economy now that the Federal Reserve won't raise intrest rates this year. » Read More
Potential Lyft investors are questioning how and when the company will make money. » Read More
Uncle Sam would shave tens of millions of dollars off the windfall before it even reaches the winner.
Levi Strauss' initial public offering marks a new era for the 166-year-old denim company, Wall Street experts say.
Bond prices are on the rise this week after the Federal Reserve again sounded a dovish call. They could keep rising, says Todd Gordon of TradingAnalysis.com.
A production halt of Boeing's 737 Max jets could be felt well beyond the aerospace giant's quarterly profits, according to J.P. Morgan.
The U.S. still has some gas left in the tank, according to Fundstrat Global Advisors.
A new Comcast device will allow its broadband-only customers to watch streaming video without an outside connected device.
DoubleLine Capital CEO Jeffrey Gundlach spoke to CNBC's Scott Wapner on Thursday.
Apple's stock rose more than 3 percent on Thursday, putting the stock on pace for its ninth positive day in the past 10 days of trading.
Corporate earnings are falling, the economy is slowing, yet the U.S. stock market is still up more than 13 percent this year.
Federal Reserve Chairman Jerome Powell's assertion this week that the U.S. economy remains strong is facing a stern test from the bond market.
How ESG data may help enhance long-term value and manage downside risk
It should come as no surprise that moving south is a popular choice for retirees. These are the top U.S. Southern cities, taking into account things such as affordability, safety and senior population.
"It's not easy to start. You make your rookie mistakes, you come back. He's a great guy," CNBC's Jim Cramer says.
Shares of Biogen plummeted Thursday after the company halted the trial of Alzheimer's disease drug aducanumab.
The Academy Award-winning actor is funding a company that could change the way you manage your money in order to help save the world.
Here are the biggest calls on Wall Street on Thursday